Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra A Lewis

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Chest|March 15, 2014
A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasisAlexandra L Quittner, Kristen K Marciel, Matthias A Salathe, et al.
The New England Journal of Medicine|August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge studyJohn P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Chest|March 15, 2014
A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasisAlexandra L Quittner, Kristen K Marciel, Matthias A Salathe, et al.
The New England Journal of Medicine|August 21, 2014
Oral GS-5806 activity in a respiratory syncytial virus challenge studyJohn P DeVincenzo, Richard J Whitley, Richard L Mackman, et al.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
Pageof 2